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Abstract 
A body of evidence indicates that peripheral nerves have an extraordinary yet limited 
capacity to regenerate after an injury. Peripheral nerve injuries have confounded professionals 
in this field, from neuroscientists to neurologists, plastic surgeons, and the scientific 
community. Despite all the efforts, full functional recovery is still seldom. The inadequate 
results attained with the “gold standard” autograft procedure still encourage a dynamic and 
energetic research around the world for establishing good performing tissue engineered 
alternative grafts. Resourcing to nerve guidance conduits, a variety of methods have been 
experimentally used to bridge peripheral nerve gaps of limited size, up to 30-40 mm in length, 
in humans. Herein, we aim to summarize the fundamentals related to peripheral nerve anatomy 
and overview the challenges and scientific evidences related to peripheral nerve injury and 
repair mechanisms. The most relevant reports dealing with the use of both synthetic and natural-
based biomaterials used in tissue engineering strategies when treatment of nerve injuries is 
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 INTRODUCTION 
The most significant advances in peripheral nerve repair and regeneration have been 
achieved over the last years with the improvement of technological tools. However, the study 
of nerve and its regenerative potential initiated in earlier times, possibly in the ancient Greek 
period [1]. Nevertheless, the establishment of the basic notions and modern concepts of nerve 
repair and regeneration were only developed in the twentieth century with the emergence of the 
neurosurgery field [2].  
Peripheral nerve injuries (PNIs) usually involve sensory and motor neurons and 
frequently result in axonal loss and demyelination, depending on the severity of the injury. 
Under ideal conditions, regeneration of a nerve cable is followed by remyelination, thus 
allowing a certain degree of sensory and functional recovery to be achieved. In the clinics, PNIs 
repair is based on the knowledge of physiological regenerative processes [3]. However, if no 
additional strategies are used, functional recovery following an injury remains incomplete. In 
order to address this tissue regeneration and improve clinical outcomes, the contribution of 
multidisciplinary fields is required. Interestingly, tissue engineering (TE) has allowed to take 
impressive steps towards the improvement of functional outcomes, by means of combining 
areas such as reconstructive microsurgery, transplantation and biomaterials [4]. Furthermore, 
the basic triad of TE has an important role in successful nerve regeneration, as the goal remains 
to develop and fabricate novel nerve guidance conduits (NGCs) built from a particular 
biomaterial, capable of housing cells and deliver biological and physical molecular cues, 
enhancing and guiding nerve regeneration [5]. As tubulization and the use of NGCs remains 
the base for nerve repair, the choice of adequate type(s) of biomaterials is the pillar to achieve 
the so desired regeneration [6]. In fact, it has been confirmed experimentally that engineered 
NGCs may also lead to effective nerve repair, that was earlier thought to only be restorable 
using autograft [7]. 
The topics related to the anatomy of the nervous system as well as on the innate 
mechanisms related to the natural attempts of tissue regeneration are addressed herein. A 
comprehensive overview of the biomaterial’s approaches being pursuit in nerve regeneration 
can also be found. Pre-clinical studies comprising natural, synthetic and endogenous 
biomaterials have also been extensively explored. Additionally, strategies to achieve nerve 
repair as well as challenges that need to be overcome are highlighted.  




 Organization of the Nervous System  
In the case of an injury, in order to make an initial assessment/diagnosis and proceed 
with the appropriate treatment, it is imperative to have plain knowledge of nervous system 
anatomy. The nervous system is the instrument through which organized vertebrates keep in 
touch with its internal structures and external surroundings, reacting to changes and adapting to 
them. This system has a fundamental role in behavior control and can be divided in the central 
nervous system (CNS) and peripheral nervous system (PNS) [8]. The CNS, composed of the 
brain and its caudal prolongation, the spinal cord, is connected to the periphery by the PNS [9]. 
During the embryonic development known as ontogenesis, the CNS emerges from the neural 
plate of the ectoderm that molds into the neural groove, from which the neural tube results. 
Subsequently, the neural tube is restructured and gives origin to brain and spinal cord. This 
phenomenon is known as neurulation. Two bands of tissue called the neural crest will give 
origin to the forthcoming PNS that run along the neural tube. These are multi-potent progenitor 
cells that later form the PNS [10]. 
At an anatomical level, the CNS consists of the brain and the spinal cord, being both 
enclosed by three types of meninges [11]. The PNS consists of cranial nerves, spinal nerves and 
their roots and branches, peripheral nerves, and neuromuscular junctions, in a total of 43 pairs 
of sensory and motor nerves [12]. Bundles of axons in the PNS are referred to as nerves. These 
are composed of more than just nervous tissue. They have connective tissue participating in 
their structure, as well as blood vessels supplying the tissues with nourishment. A neuron 
consists of a cell body, known as Soma, which gives out extensions in PNS, called axons. These 
are crucial for targeting distant tissues and organs. Axons are coated with myelin sheath 
membranes, formed by Schwann cells.  
Anatomically, each individual axon is firstly protected by a myelin sheath and sheltered 
by a first layer of collagen and elastic elements, the endoneurium. A group of endoneurium 
protects axon groups into nerve fascicles, which are sheathed by the perineurium, mainly 
composed of connective tissue. Finally, several fascicles are gathered together by the 
epineurium. In the outer layer, the mesoneurium can be found, which also comprises blood 
vessels supplying oxygen and nutrients to the nerve. Any break or defect in this stratified 
structure fallouts in a programmed and permanent cell death, unless rapidly and meticulously 
reestablished [13]. Besides myelinated nerve fibers, the PNS contains unmyelinated fibers, with 
the majority found in the cutaneous nerve, the dorsal roots, and some muscle nerves. Fig. 1 
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shows the schematic representation of CNS and PNS in the human body, as well as detailed 
anatomy of peripheral nerves and neurons.  
Myelin is a constant in both PNS and CNS. Myelin found on neurons in the PNS is 
formed by Schwann cells while myelin found in the CNS is generated by oligodendrocytes. 
However, one striking difference can be pointed. In one hand, oligodendrocytes and Schwann 
cells are often compared to each other in terms of function. However, the biggest difference 
among the two resides in their ability to repair neurons after nerve damage, as Schwann cells 
promote nerve regeneration and repair, whereas oligodendrocytes inhibit neuron repair after an 
injury [14]. 
In terms of purpose, the primary function of the CNS is integration. Conversely, the 
PNS is mainly a receptor and effector organ that connects the CNS to every part of the body by 
cranial and spinal nerves, and associated ganglia. This connection is made by sensory and motor 
neurons that conduct impulses to the CNS or the periphery, respectively [15].  
 
 General Overview of Peripheral Nerve Injuries 
Neurological defects are among the most demanding clinical situations despite decades 
of research in the neurological field [16]. The reason for this relies in the complexity of the 
nervous system functions, structure and anatomy, which makes it more challenging to treat as 
compared to other tissues in the human body [17]. Opposing to the CNS, the PNS is not 
protected by a hard bone layer or by the blood-brain barrier, making it much more disposed to 
traumatisms or any kind of injuries [18]. Therefore, PNIs are considered a huge clinical burden, 
being the incidence 1 in 1,000 individuals per year [19]. The estimated numbers of PNIs range 
from 300,000 and 360,000 cases per year for Europe and the USA, respectively [20]. In fact, 
PNIs are associated to $150 billion health-care expenses per year in the USA alone [15]. These 
costs are underestimated, since “bed-days” and lack of productivity also account for monetary 
losses, worldwide. It has been assessed that 25% of patients suffering from traumatic injuries 
and undergo surgery do not return to work 1.5 years after the intervention. 
 





Fig. 1 - Schematic representation of nervous system anatomy in the human body. The nervous system is divided 
in CNS (in blue) and PNS (green). A) The PNS is composed of several pairs of nerves, which transmit signals 
between afferent sensory neurons and efferent motor neurons to the CNS; B) CNS, composed of the brain and 
spinal cord, which has connections to PNS. In CNS, interneurons receive information from the periphery; C) 
A peripheral nerve contains many nerve fibers that are held together by connective tissue and bundled into nerve 
fascicles. The entire nerve is enclosed by connective tissue called epineurium. Individual fascicles are delineated 
by perineurium. Endoneurium surrounds each nerve fiber; and D) Each neuron is composed of a cell body, known 
as Soma, which contains dendrites. The axon, elongating from the cell body may present myelin sheaths. The 
spaces between the myelin sheaths are Nodes of Ranvier. In the end of the neuron there is an axon terminal, which 
releases neurotransmitters from one neuron to another.
This scenario tends to worsen with the increasing world population and respective 
average lifespan. Considering those, an additional number of injuries tend to appear and 
consequently a high number of treatments and surgeries will be required to allow the restoration 
of the damaged nerves [21]. Although the CNS is vastly protected and therefore less prone to 
injuries, it has a limited ability to regenerate because of the succeeding scar tissue development 
which can be created by a vast range of cell types, such as fibroblasts, neuroglia, monocytes, 
and endothelial cells [22]. In contrast, PNIs are considerably more common, but the peripheral 
nerves have a greater regeneration potential as compared to the nerves of CNS. This is because 
PNS glial cells, Schwann cells, adjust to a regenerative phenotype and have the capacity of 
triggering neuronal regenerative processes, although usually slow and in a partial manner [23]. 
The regeneration process, however, is dependent on certain factors, such as the lesion size and 
the quality of the affected nerve, the person’s health statues (e.g. diabetic or non-diabetic), age, 
and most importantly, the time period from injury to surgical reconstruction. In the case of 
lengthy time without repair, the distal nerve end and target tissues and organs are chronically 
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denervated, becoming chronically axotomized, which leads to neurons undergoing apoptosis 
[24].  
Given to their exposure, peripheral nerve damages can be caused by many types of 
events, such as traumatic injuries, complications on surgeries, congenital defects and war 
wounds. Concerning the traumatic injuries, they can also vary significantly and include tearing 
injuries, crushing or smashing, ischemia, and less prevalent types of injury such as thermal, 
electric shock and radiation [25]. Compression neuropathies are also ubiquitous among nerve 
injuries. For instance, carpal tunnel syndrome, the most common compression type of injury, 
affects 4% of the overall population [26]. A vast range of diseases can also be the root cause of 
PNIs, as is the case of diabetic peripheral neuropathies [27, 28]. Most of these traumatic events 
cause neuronal death, demyelination, and axonal degeneration resulting in persistent 
complaints, such as impaired sensory and motor nerve functionality and radiating neuropathic 
pain. Disorders concerning the PNS usually have overwhelming and life-disturbing impacts on 
patients’ daily functions and habits, which are not usually regarded as significant. There is a 
substantial lack of consideration of the impact of injury on social and emotional wellbeing, 
despite their importance to patients. There is, in fact, a strong correlation between PNIs and 
pain and depression in those patients [29]. 
Due to the great variety of peripheral nerve traumas, there was a categorization of nerve 
injuries in main domains, as an attempt to systematize them for the medical and scientific 
community.  Several degrees of injury to peripheral nerves are detailed in Table 1, which were 
firstly described by Seddon [30], and later by Sunderland [31]. 
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The Seddon classification is divided into three categories according to the gravity 
of the injury: i) neurapraxia, ii) axonotmesis, and iii) neurotmesis. By its turn, Sunderland 
classification comprises five different categories: first, second, third, fourth and fifth 
degree. Seddon classification is more straightforward and therefore the most used. 
Neurapraxia is the least severe type of injury and it is not associated with long-term 
impairments and consequences. The second level, axonotmesis, is related to axon and 
myelin discontinuity or disruption. The most severe type, neurotmesis, involves the 
complete disconnection of the nerve, where a gap is formed.  
 
 Degeneration and Regeneration processes following PNIs  
Immediately after injury, the regeneration process of peripheral nerves runs in 
sequenced phases and different events occur at different levels on the injury site encompassing 
both proximal and distal sites (Fig. 2A) [32]. In the proximal position, separated axons and cell 
bodies degenerate via a programmed cell death pathway called chromatolysis [33]. In the distal 
injury end, a process called Wallerian degeneration occurs 24 to 48 hours after injury and all 
nerve components, including the distal axons and adjacent myelin starts to degenerate [34]. The 
goal of that phenomenon is related to the clearance of undesired debris. Schwann cells 
phagocytize axonal and myelin debris, until only empty endoneurial tubes remain. Normal 
nerve function depends on such type of cells, which are the myelinating glial cells of the PNS 
[35, 36].  
After debris removal, Schwann cells fill the empty endoneurial tubes and organize in 
characteristic bands or tubes of Bungner, and by this mean supporting the re-growth of axons. 
Not only Schwann cells have a crucial role, but also macrophages are recruited to the area 
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releasing growth factors and cytokines. The release of cytokines will stimulate Schwann cells 
and fibroblast proliferation and are responsible for the axonal regeneration process [37]. Ahead 
in the process, in the proximal injury end, a growth cone emerges following the path formed by 
the band of Bungner, which is of fundamental importance for the advance of the regenerating 
axon [38]. The growth cone can be seen in Fig. 2B [39]. In optimal conditions, axonal 
regeneration is very slow, occurring at a rate of approximately 1 mm/day and demanding at 
least more than one year for muscle re-innervation and initial functional recovery [40].  
 





Fig. 2 – A) Progression of Wallerian Degeneration: I) A single axon with enwrapping myelinating Schwann cells 
suffers a traumatic injury; II) The axon breaks and the distal stump undergoes cellular changes. Distal to the injury, 
there is a destruction of the remaining intact axon and disintegration of myelin cover, leaving debris behind. 
Macrophages and Schwann cells, which turned to a pro-regenerative phenotype, accumulate at the lesion site and 
scavenge the debris; III) Schwann cells aligns in the Bands of Bungner. These tubes provide a permissive growth 
environment and guide extending axons towards distal targets; IV) If the axon is able to traverse the injury gap, 
the distal target becomes re-enervated and the neuron becomes fully functional; and B) The growth cone is a large 
actin-supported extension of a regenerating neurite pursuing its corresponding synaptic target. It is responsible for 
the migration and path finding during neurite extension, in which the lamellipodia and filopodia interact with the 
adjacent matrix.  
After debris removal, Schwann cells fill the empty endoneurial tubes and organize in 
characteristic bands or tubes of Bungner, and by this mean supporting the re-growth of axons. 
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Not only Schwann cells have a crucial role, but also macrophages are recruited to the area 
releasing growth factors and cytokines. The release of cytokines will stimulate Schwann cells 
and fibroblast proliferation and are responsible for the axonal regeneration process [37]. Ahead 
in the process, in the proximal injury end, a growth cone emerges following the path formed by 
the band of Bungner, which is of fundamental importance for the advance of the regenerating 
axon [38]. The growth cone can be seen in Fig. 2B [39]. In optimal conditions, axonal 
regeneration is very slow, occurring at a rate of approximately 1 mm/day and demanding at 
least more than one year for muscle re-innervation and initial functional recovery [40].  
1.3.1. The role of Schwann cells in injury response 
Schwann cells are among the first active components after nerve injury. Finding their 
embryologic origin in the neural crest, Schwann cells have the capacity to proliferate, produce 
and deliver neurotrophic factors, modulate the immune response, myelinate axons, migrate and 
adjust their shape and phenotype. This makes them the perfect cells towards intervening in 
neural repair [41].   
Although the degeneration of axons in the distal nerve end starts roughly 2 days after 
injury, activity of Schwann cells can be distinguished before that, within hours of injury, where 
Schwann cells undergo a phenotypic change [14]. This phenotypic change will support PNR in 
several ways. Firstly, they dedifferentiate by means of acquiring a non-myelinating and 
immature Schwann cells stage phenotype. That stage is characterized by an up-regulation of 
L1, NCAM, p75NTR, and glial fibrillary acidic protein (GFAP). On the other hand, myelin-
associated genes are down-regulated, which comprise myelin transcription factor Egr2, 
organizational and mechanical supporting proteins as such as Protein 0 (P0), myelin basic 
protein (MBP) and myelin associated glycoprotein [42]. There is also an up-regulation and 
secretion of a beneficial group of trophic factors, such as nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), basic fibroblast 
growth factor (bFGF), vascular endothelial growth factor (VEGF) and pleiotrophin [43]. 
Furthermore, the expression of cytokines capable of recruiting macrophages is also up-
regulated, which include tumor necrosis factor (TNF)-α, LIF, interleukin (IL)-1α, IL-1β, and 
monocyte chemoattractant protein 1 (MCP-1). Schwann cells activate a cell-intrinsic myelin 
breakdown process, which will destroy myelin by an autophagy process, roughly at the 5th day 




after injury [23]. This is a key process intimately related to increasing the regenerative potential 
after injury. In fact, elimination of degenerated myelin is fundamental for repair since PNS 
myelin holds molecules that inhibit regeneration of severed axons, namely the myelin 
associated glycoprotein [44]. At last, Schwann cells response to injury also includes the 
formation of regeneration tracks, known as Bands of Bungner. For that, Schwann cells adopt 
the elongated spindle-shape morphology and line up in columns. To perform such task, they 
express a variety of adhesion molecules on their surface, such as N-cadherin, L1 and N-CAM. 
Extracellular matrix (ECM) molecules are also secreted, such as laminin and fibronectin. All 
the secreted molecules are considered guidance-promoting signaling molecules, important not 
only during early development, but also to create a microenvironment that mediates axon 
regrowth and guidance, allowing axons to reconnect with their target tissues [45].  
Overall, Schwann cells acquire a pro-regenerative phenotype, capable of promoting 
nerve repair, when there is a conversion of myelin-Schwann cells to repair-Schwann cells. The 
single protein capable of this transformation is c-Jun, which is rapidly up-regulated in the distal 
nerve end Schwann cells after injury [46]. 
 
 Strategies for Nerve repair 
Clinically, the straight-forward technique to repair minor nerve defects is the end-to-end 
suture [47]. However, this technique is circumscribed to a maximum gap length ranging from 
5 mm to 20 mm, depending on the nerve, since the suture must be done without creating 
excessive tension in the nerve ends. When the nerve gap length makes end-to-end suture 
unfeasible, peripheral nerve grafts are the gold standard treatment for nerve restoration. In a 
technique that dates to Philipeux and Vulpian in 1817 [48], the insertion of a graft section 
provides a physical and biological scaffolding, over which axonal outgrowth occurs. Grafts can 
be autologous, known as autografts, or allografts. The use of autografts has inherent 
disadvantages, such as donor site morbidity and reduced availability [49]. For allografts, the 
tissue is harvested from another donor, which can increase the risk of disease transmission and 
immunological response. However, related to allografts, a recent and promising alternative for 
patients who have exhausted all reconstructive methods is the vascularized composite tissue 
allotransplantation (VCA) [50]. Furthermore, tacrolimus, one of the immunosuppressant drugs 
that will accompany the patients for a life-time when subjected to this procedure, has shown to 
have positive effects in PNR [51]. 
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However, despite those seemingly good chances of recovery with grafts, incomplete 
recuperation from PNIs usually can lead to multiple negative consequences, which comprise 
numbness of affected members, chronic pain, diminishing of sensory and/or motor function and 
a disturbing permanent disability of the patients [52]. It is a fact that these outcomes are 
unsatisfactory for the demands of today’s patient lives, since only 25% of patients regain proper 
motor function, and less than 3% recuperate sensation in a full extent [53].  
Decellularized nerve conduits are another possibility for nerve repair [54]. In order to 
avoid the need of immunosuppressive drugs associated to allografts requirements, which make 
the patient more prone to acquire infection and tumors, the decellularized nerve conduits can 
eliminate the cellular components that cause immunogenic reactions. However, the native ECM 
is conserved, along with the basal lamina, the guiding mechanical cues for axonal growth is 
maintained. Several methods can be used to decellularize nerves, among them, physical 
methods such as lyophilization [55], direct pressure, and agitation [56]. Chemical methods have 
also been attempted and include digestion with alkaline or acidic solutions [57], detergents [58], 
together with the action of enzymes such as trypsin and endonucleases [59]. Various studies 
support the hypothesis that decellularized grafts are among the best options for nerve repair, 
since they can bridge more than 10-20 mm long gaps in rats [60, 61]. However, as concluded 
by the authors who performed a 10-year review of the use of allografts for PNR [54], further 
research is desirable in order to improve and standardize preparation protocols, including 
recellularization, advance their effectiveness, therefore being able to substitute the current gold 
standard, especially in the repair of long nerve defects. 
For these reasons, increasing efforts have been made over the last decades in the search 
for effective alternatives to autografts. Surgical treatment strategies in the case of PNI can be 
seen in Fig. 3. 
In an attempt to overcome the limitations of nerve grafting as well as the unsatisfactory 
outcomes, TE approaches focusing on the development of innovative biocompatible artificial 
nerve devices to assist innate regeneration processes to re-establish the peripheral nerve have 
also been reported [62, 63]. TE strategies have been a widely travelled alternative to bridge the 
nerve gap and throughout the years many types of NGCs were proposed, being some of them 
already approved by the Food and Drug Administration (FDA) [64, 65]. Since mature neurons 
are not susceptible to mitosis phenomena, it is crucial to support the re-growth of the existing 
cell bodies, providing both a protective environment and guiding paths. In this way, it is 




possible to direct axons from the proximal to the distal site, permitting the proper linking of the 
damaged synapses connections. In brief, the protection of the injury site and performance as a 
guidance substrate are the two main reasons why tubulization is used in PNIs.  
Engineering a NGC should aim at facilitating cellular spreading and growth of damaged 
nerve tissues in 3-dimensions (3D) [66]. In addition, it is crucially important that the material 
envisioned to be used to construct the NGC is cytocompatible and has pronounced 
biomechanical properties, and suturability. If an engineered NGC does not present a proper 
cytocompatibility, it may not contribute to the growth of damaged nerves, but would instead be 
the reason of acute inflammation and even infection [67]. It must exhibit good biocompatibility 
with low inflammatory and immunogenic reactions [68]. It must also be biodegradable, and 
ideally degrade in the same rate as nerve regenerates. Otherwise, a quick degradation might 
trigger an inflammatory response [66, 69]. Regarding the mechanical properties, the NGC 
should provide sufficient mechanical strength to prevent the NGC rupture during the patient’s 
movements and physically support neural tissue regeneration. Concurrently, the NGC should 
have appropriate elasticity to be able to lessen tensions in the damaged area [67]. Two other 
major features that NGCs must possess are related to the suturability, where the suture thread 
cannot be pulled out of the material when in physical stress [70]. The second feature relates to 
the ability of a medical device to not calcify when implanted in vivo. Such characteristic must 
be previously tested and avoided at all costs, since calcification of a conduit would hinder 
regeneration in a great extent. In fact, Carvalho et al. [71] recently reported on a silk fibroin 
NGC that would or not calcify, according to the method of solvent removal and final surface 
properties.  
Furthermore, the materials used to construct NGCs should prevent the penetration of 
fibroblasts that will lead to the formation of glial scar tissue around the implant, which could 
reduce the healing chances [72]. The permeability of a conduit is also an important parameter 
to consider in the NGC design as both nutrients and oxygen must diffuse into the site of 
regeneration. 
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Fig. 3 - Strategies for nerve repair. In the case of a significant nerve gap formation where end-to-end coaptation is 
not possible, nerve grafts or engineered NGCs are required to serve as a bridge between the nerve stumps and to 
support axonal regrowth. In the case of grafts, they can be from the patient her/himself, known as the autografts. 
Allografts and xenografts are also a possibility. As an alternative, if the option falls in the NGCs, those can be 
nerves harvested from the body, which undergo a process of decellularization to avoid immunological reactions, 
maintaining the ECM for physical support. NGCs can also be manufactured and engineered with biological or 
synthetic materials, as well as a combination of both. 
Otherwise, cells inside the conduit, especially if it is a long conduit, will be under a 
deleterious ischemic environment which can result in cellular hypoxia and lack of proper 
nutrients. Ideally, electrical conductivity would be preferred for a NGC used in neural TE in 
order to mimic the electrical properties of nerves and at the same time excite the neuron 
communication [73]. The parameters to be considered for the design of NGCs are summarized 
in Table 2 [74-82]. In brief, an ideal NGC should be biocompatible, biodegradable, flexible, 
kink-resistant, compliant, easy suturable, porous, neuroconductive and with suitable surface 
and overall mechanical properties [79]. Furthermore, the developed NGC should allow 
vascularization to occur in the lumen and avoid calcification in vivo. 
 
Table 2 - Design criteria for the development of NGCs.  
Ideal properties of NGCs Detailed description 
Biocompatibility 
Must be well incorporated in surrounding tissues and not cause 
inflammatory response [74]; 
Degradation Degradation rate should match nerve regeneration rate [75]; 
Porosity 
NGC must allow nutrient and oxygen exchange, limiting scar tissue 
infiltration [76];  





The NGC conduit itself or the luminal filler should be aligned to provide 
directional guidance [77]; 
Adequate protein release 
NGC or the luminal filler should provide sustained release of growth 
factors [78]; 
Physical fit Adequate internal diameter not to compress the growing nerve [79]; 
Cellular support 
Must allow the adhesion and proliferation of relevant cell types, such as 
Schwann cells and endothelial cells[80]; 
Electrically conducting Capable of propagating electrical signals [81]; 
Vascularization 
The NGC must allow the vascularization to occur inside the NGCs, to 
nourish the regenerating tissue [82]; 
Calcification The implantable NGC must not calcify in vivo [71]; 
Suturability 
The NGC must withstand a suture being pulled out without breaking the 
biomaterial [83]. 
In the early use of NGCs made of synthetic materials, they were mainly composed by 
silicon tubes and could only repair injuries up to 10 mm. Some disadvantages on the use of that 
conduits included total lack of biodegradability, which led to inflammation and chronic foreign 
body reaction, as well as lack of swelling capacity, which would compress the nerve, thus 
hindering the regeneration process [84]. In order to overcome such difficulties, biodegradable 
NGCs have been proposed, some of which are FDA-approved and being currently used in the 
clinical setting [65]. The FDA approved NGCs can be seen in Table 3 [65]. 
 
Table 3 - Approved NGCs used in the clinical setting. 






Integra Neurosciences, NJ, 
USA 
Collagen type I 
36-48 months 
NeuraWrap™ 
Integra Neurosciences, NJ, 
USA 
Collagen type I 
36-48 months 
Neuromend™ 
Collagen Matrix, Inc, NJ, 
USA 
Collagen type I 
4-8 months 
Neuromatrix/Neuroflex™ 
Collagen Matrix, Inc, NJ, 
USA 
Collagen type I 
4-8 months 
Neurotube® 
Synovis Micro Companies 
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Cook Biotech Products, IN, 
USA 
Porcine small intestinal 
submucosa matrix 
N/A 
Avance® AxoGen Corporation, USA Human nerve allograft N/A 
1.4.1. Biomaterials 
1.4.1.1 Synthetic biomaterials  
Regarding the synthetic materials, these are still considered very promising since the 
majority of the FDA-approved NGCs are composed of materials such as Neurotube 
(polyglycolide acid, PGA) and Neurolac (poly(L-lactide-co-ε-caprolactone, PLCL). Other 
synthetic materials widely used in PNR are polylactic acid (PLA), polylactic-co-glycolic 
(PLGA), polycaprolactone (PCL), and polyhydroxybutyrate (PHB). In brief, synthetic nerve 
conduits provide higher degree of controllability, better mechanical properties, and poor 
bioactivity as compared to their natural equivalents [65]. Moreover, these materials are known 
for low inflammatory response and effortlessness processing, which means they can be 
processed in a variety of forms, to enhance nervous tissue growth. However, in spite of the 
referred positive characteristics of synthetic polymers, a few disadvantages are also reported 
[85]. The main negative aspects are related to suboptimal biodegradation and possible toxic 
biodegradation byproducts. These drawbacks block their extended use in the clinics [86]. Fig. 
4 shows some promising results considering synthetic biomaterials applied to PNR. From Table 
4, it is also possible to find the most recent and relevant reports considering the use of synthetic 
biomaterials in PNR [87-99]. 
PLA 
PLA has been used as a nerve conduit material in a few studies.  Matsumine et al. [87] 
developed a biodegradable nerve conduit with PLA non-woven fabric and evaluated its nerve 
regeneration promoting effect. The conduit made of randomly connected PLA fibers 
demonstrated a comparable ability as the autograft to induce PNR in the buccal branch of a 7 
mm facial nerve defect. Another author developed a biodegradable multi-layer microbraided 
PLA fiber-reinforced conduit with outstanding mechanical properties, which revealed to be a 
promising tool for neuro-regeneration [88]. 





PLLA is the crystalline form of PLA. In a study by Zeng et al. [89], several topographies 
were achieved in the PLLA conduit using low-pressure injection molding and thermal-induced 
phase separation, including a nano-fibrous microstructure, microspherical pores and nano-
fibrous pore walls and a ladder-like microstructure. Of all the topographies experimented, the 
nano-fibrous microstructure allowed the differentiation of neural stem cells (NSCs) into 
neurons. Also paying a lot of attention to the inner structure of the NGC, others have developed 
a conduit that consists of a porous poly(D,L-lactic acid) (PDLLA) tubular support structure 
with a micropatterned inner lumen pre-seeded with Schwann cells [90]. Such device delivered 
physical, chemical and biological guidance cues. 
PGA 
The use of PGA is not very common in PNR field. However, of the clinically available 
NGCs, PGA has the most rapid degradation rate and it is FDA-approved (Neurotube®). When 
testing Neurotube® for facial nerve repair, it was found to be an effective substitute to 
autologous nerve grafts. However, the authors reported a few limitations to this NGC, which 
consist in the fact that it can only be used with gaps of less than 30 mm, it is quite costly and 
intolerance cases have been reported [92]. When compared to other FDA-approved conduits, 
Neurotube® achieved the poorest result in terms of nerve regeneration [91]. 
PLGA 
PLGA is one of the most attractive synthetic polymers and broadly used in PNR. This 
FDA-approved material gives rise to very low inflammatory responses, and its degradation can 
be easily controlled by altering the ratio of its monomer components. Additionally, PLGA 
scaffolds have the unique ability of adhering to Schwann cells and directing their growth [100]. 
A recent study focused on producing a laminin-coated and yarn-encapsulated PLGA NGC [93]. The 
PLGA fiber yarns were fabricated through a double-nozzle electrospinning system and then the 
PLGA fibrous outer layer was collected using a general electrospinning method. The conduit 
demonstrated adequate mechanical properties as well as promising potential in promoting Schwann 
cells proliferation and migration. In another study also focused on different topographies [101], 
it was developed a hybrid-structured nerve conduit which consists of a PLGA microfibrous 
bundle wrapped in a micro/nanostructured PLGA membrane. This device demonstrated high 
capability for guiding nerve cells and promoting cell migration. Many other studies using PLGA 
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were developed, inclusively with conduits capable of releasing NTFs or other neuroprotective 
molecules such as salidriside and Nectin-like molecule 1 (NECL1) [94, 102, 103]. 
PCL 
PCL is one of the most used polymers in TE [104]. It has been broadly applied in bone 
[105], cartilage [106], cancer defects [107], and drug delivery applications [108]. It is a 
biodegradable semi crystalline linear polyester produced by ring-opening polymerisation of e-
caprolactone with a low melting point of around 60 °C. For the mentioned biodegradable 
polyesters mentioned so far, in vivo degradation rate is in the order PCL < PLA < PGA. Due to 
PCL's very low in vivo degradation rate and high drug permeability, it has been found to be 
useful in long-term implantable delivery devices [109]. Bearing in mind that polymeric 
bioabsorbable conduits can be used as drug delivery systems, Salmoria et al. [110] produced 
PCL conduits by melt extrusion technique, which were loaded with ibuprofen. PCL is also a 
very attractive polymer for the rapidly emerging and recently popular 3D printing technology. 
In a study recently published by Lee et al. [95], combination of stereolithography and 
electrospinning techniques allowed to fabricate a novel 3D biomimetic PCL neural scaffold 
with tunable porous structure and embedded aligned fibers. The results indicated that PCL 
fibers greatly increased the average neurite length and directed neurite extension of primary 
cortical neurons along the fiber. Quite often, polyesters are blended with other components to 
make composite NGCs which allows to improve their mechanical properties and control the 
general features of the NGCs in more detail [96, 111-114].  
PU 
Created by a water-born process, PU has recently been applied as the base material for 
the construction of a novel NGC [97]. The NGC was built through the freeze-drying technique 
and presented an asymmetric microporous structure that allowed bridging a 10-mm gap in rat 
sciatic nerve. The results, in terms of nerve regeneration, were remarkable. Inclusively, based 
on functional recovery and histology findings, the efficacy of PU NGC was superior to that of 
commercial conduit Neurotube®, to which it was compared. Recently, an antioxidant-PU 
conduit was developed using the electrospinning technique by Singh et al. [98] and further 
filled with an aligned chitosan-gelatin cryogel filler. The in vitro cellular tests with dorsal root 
ganglia (DRGs) cultures showed the aligned growth and cellular migration along the pores, 
indicating that both the outer part of the conduit as well as the luminal filling are potentially 
appropriate for PNR.  





PVA is another synthetic polymer used in the construction of NGCs. It is water soluble 
but non-degradable, being considered non-resorbable. There is currently FDA-approved NGCs 
made of PVA hydrogels, named SaluBridge™ and SaluTunnel™. However, such devices have 
not been validated with accessible pre-clinical or clinical studies. It can also be stated that the 
utilization of nonabsorbable conduits has declined with the crescent use of absorbable synthetic 
grafts [115]. To improve that, Stocco et al. [99] recently manufactured a conduit made of a 
patented and novel biodegradable hydrogel, oxidized PVA (OxPVA). An in vitro and in vivo 
battery of tests revealed that OxPVA scaffolds performed very similarly to the autograft group. 
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Fig. 4 – Promising results obtained with synthetic polymers applied to PNR. A) A non-woven polylactic acid 
(PLA) tube. Scale bar: 1 mm; B) SEM images of the PLLA multi-channel conduits cross-section using different 
magnification. Scale bar: 500, 100 and 10 µm, from top to bottom; C) Scanning electron micrograph of double-
walled microsphere following incorporation into PCL nerve guides; and D) Gross appearance of disk-shaped and 
tubular scaffolds made of OxPVA. A), B), C), and D) were reprinted with from [87],[89], [96] and [99], 
respectively. 
 
1.4.1.2 Natural-origin Biomaterials 
Natural-origin biopolymers used for the fabrication of NGCs typically have regenerative 
bioactivity along with appropriate mechanical properties. Natural biomaterials allow for 
improved communications between cellular components and the scaffold is also an advantage 
since cells must be stimulated to proliferate, benefiting tissue regeneration [116]. However, 
some restrictions are associated to natural-origin biomaterials, such as the batch to batch 
disparities [117]. In the section below, interesting and recent reports using natural-origin 
biomaterials for PNR applications, from proteins (e.g., silk fibroin and keratin) to 
polysaccharides (e.g., chitosan and alginate) will be reviewed. Fig. 5 shows some promising 
results obtained with natural-origin biomaterials, in particular using silk fibroin, chitosan and 
alginate polymers. The significant works considering the use of natural-origin biomaterials in 
PNR are summarized in Table 5 [118-129].  
  














Non-woven material, melt blown process Facial nerve, 7 mm gap, rat 
Comparable ability to induce PNR as autologous 
nerve graft. 
2014, [87] 
Multi-layer, micro-braided, fiber-reinforced conduit 
Sciatic nerve, 10 mm gap, 
rat 
Successful regeneration with cables bridging the gap. 2009, [88] 
PLLA 
Low-pressure injection molding and thermal-induced 
phase separation technique, 33 inner channel NGC 
In vitro assays with NSCs 
 
81.1% of NCSs differentiated into neurons. 2014, [89] 
Porous PDLLA conduit achieved by dipping method, 
with micropatterned inner lumen by ion etching. Pre-
seeded with Schwann cells 
Sciatic nerve, 10 mm gap, 
rat 
Presence of Schwann cells did not affect results, 
speed of functional recovery was enhanced. 
2004, [90] 
PGA 
Neurotube® is fabricated to form a knitted or woven 
tubular device 
Segmental nerve defect, 10 
mm gap, rat 
Exhibited the poorest results for functional motor 




Facial nerve, 10–30 mm gap, 
humans 
Valid solution for this kind of defect in emergency. 




PLGA fibrous outer layer produced by electrospinning and 
containing laminin coated yarns obtained by double-nozzle 
electrospinning 
In vitro assays with 
Schwann cells 
Significant higher proliferation and elongation of 
Schwann cells along the inner yarns. 
2017, [93] 
Two concentric biodegradable PLGA tubes enclosing a 
NGF reservoir. Solvent casting method 
Sciatic nerve, 15 mm gap, 
rat 
Optimal release levels of NGF; Improved muscle 





3D printed conduit embedded with electrospun aligned 
nanofibers 
In vitro assays with NSCs 
and primary cortical neurons 
Increased average neurite length and directed neurite 
extension along the fiber. 
 
2017, [95] 
PCL conduits were fabricated by dipping and 
incorporate double-walled PLGA/PLA microspheres 
encapsulating GDNF 
Sciatic nerve, 15 mm gap, 
rat 
GDNF increased tissue formation within the nerve 
guide lumen and promoted the migration and 
proliferation of Schwann cells. 
 
2010, [96] 
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PU 
Mold casting followed by freeze-drying, producing a 
porous scaffold 
Sciatic nerve, 10 mm gap, 
rat 
Significantly greater efficacy of the PU conduit when 
compared to the commercial Neuratube®. 
 
2017, [97] 
Electrospun Antioxidant-PU conduit filled with freeze-
dried aligned chitosan-gelatin cryogel 
In vitro study with neuro 2a, 
C2C12 and DRGs. 
DRGs demonstrated aligned growth of the neurites 




SaluBridge™, implantable wrap N/A 




Dipping technique of OxaPVA hydrogel Sciatic nerve, 5 mm gap, rat 
Axon density in the middle of the conduit 
significantly higher as compared to autograft. 
2018, [99] 
 





Silk fibroin  
Silk fibroin (SF) is a fibrous protein with remarkable mechanical properties 
produced by silkworms and spiders [130]. Silk polymers consist of repetitive protein 
sequences and provide structural roles in nature, such as cocoon formation, nest building 
and web creation [131]. With very low immunological response, capacity to be 
transformed in diverse shapes and matrices, tunable degradation as well as easily 
chemically modified, SF has the potential to impact the clinical needs in terms of nerve 
regeneration [132]. Beyond PNR, SF has been extensively applied in the TERM field 
with very distinctive applications [133-135]. 
Carvalho et al. [71] produced tunable enzymatically cross-linked SF NGCs, 
resourcing to tyrosine groups present in silk structure that are known for allowing the 
formation of a covalently cross-linked hydrogel. The fact that the process involves an 
enzymatic crosslinking allows tuning several parameters in the final conduit, i.e. from its 
mechanical properties to porosity or biological properties.
 
 
Fig. 5 - Promising results obtained with natural-origin polymers applied to PNR. A) Example of an 
enzymatically crosslinked SF nerve guidance conduit developed and patented by Carvalho et al. [71] for 
application in PNR. The developed NGC presents outstanding mechanical properties, with kinking-resistant 
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capacity and suturability, as can be seen by the images (in that row); (B) Images of a 5% of degree of 
acetylation chitosan membrane, which can be further used as a NGC by rolling-up or in a different strategy, 
as a luminal filler; C) 5% degree of acetylation chitosan membrane incorporating human hair keratin, 
developed at our research institute; and D) Confocal laser microscopy showing macro-
porous alginate fibers incorporating gelatin particle porogens. Scale bars: 500 µm.
 
One of the advantages of SF relies on the ability to be processed in a variety of 
shapes. Dinis et al. [136] developed a 3D multi-channel SF conduit through 
electrospinning system encompassing approximately 12 multi-channel guides of different 
sizes inside the main conduit, mimicking the native structure of the nerve endoneurium, 
perineurium, and epineurium. In fact, due to the outstanding properties that several silk 
NGC have demonstrated after decades of research, there is an active clinical trial 
(NCT03673449) with SilkBridge. Such device is a biocompatible SF-based matrix that 
aims at attracting the patients' native cells to regenerate the nerve, i.e. without the need to 
add cellular components previous to the implantation. The SilkBridge is also being used 
in digital nerve defects.  
Keratin 
Keratin protein has been recognized as biomaterial with high potential due to its 
excellent bioactivity and biocompatibility [137]. Lately, the hair keratin has gained much 
attention [138, 139], not only because of its properties, but because the follicle itself is a 
bizarrely proliferative organelle that illustrates an extremely arranged regenerative 
process. Also, the fact that it is potent naturally derived biomaterial, is human-derived 
and possesses cellular interaction sites making it an attractive protein in TE applications 
[140]. 
So far, little has been done concerning the application of hair keratin to PNR. All 
in vivo work done with keratin in the scope of PNR has been developed under the 
supervision of the scientist Van Dyke at the Wake Forest University [122-124, 141].  
Chitin and Chitosan  
Chitin and chitosan are two of the most popular natural biopolymers in the TE 
field, as well as in the area of nerve repair [142]. Chitin is a natural biopolymer normally 
present in the exoskeletons of arthropods and the shells of crustaceans, being the main 
sources, in fact, the marine crustaceans such as shrimp and crabs. It is a linear 
homopolymer composed of N-acetyl-D-glucosamine units that form beta-(1-4)-linkages. 
The most abundant polysaccharide in nature is cellulose, immediately followed by chitin 
[143]. On the other hand, chitosan is obtained through the partial deacetylation of chitin. 





It is a polysaccharide composed of D-glucosamine and N-acetyl-D-glucosamine units 
linked through beta-(1–4)-glycosidic bonds. Soluble in acidic aqueous media, chitosan, 
is finding applications in many areas, such as food, cosmetics and biomedical fields [144].  
It has early been proved that chitin and chitosan-based scaffold can allow the 
attachment, migration, and proliferation of Schwann cells as well as of DRGs, two of 
main players in the nerve regeneration process [145-148]. Furthermore, chitosan 
biomaterials encourage the aligned orientation of Schwann cell and growing axons [149-
151], which is a relevant phenomenon in the process of Wallerian degeneration and 
consequent regeneration. Additionally, chitosan-based NGCs are easily handled, and 
transparency facilitates surgical manipulation and suturing of the nerve stumps. 
Due to the recognized potential of chitosan, a chitosan-based nerve conduit under 
the name Reaxon® Nerve Guide manufactured by Medovent GmbH (Mainz, Germany), 
in accordance with the international standard DIN EN ISO 13485, was launched in the 
market in 2014. These conduits were thoroughly investigated in a report by Haastert-
Talini et al. [152], where the referred conduits combined several pre-requisites for a 
clinical acceptance; and the tube with a degree of acetylation of 5% was considered as 
the most supportive for peripheral nerve regeneration to bridge a 10 mm gap. That 
conduits were used in a critical sized nerve gap [64] and in type 2 diabetic Goto-Kakizaki 
rats [153], confirming their good in vivo performance. 
Alginate  
Alginate is a broadly used bioresorbable polysaccharide in the food industry, 
wound management or in the TE field. It is a block co-polymer consisting of beta-d-
mannuronic acid and alpha-l-guluronic acid, extracted from brown seaweed [154]. It is 
considered a biocompatible material which has no inhibitory effect on cell proliferation 
in vitro and induces reduced foreign body reaction when implanted in tissues in vivo 
[155]. It has been described that calcium ions induce specific associations between 
alginate chains, consequently forming hydrogels [156]. Using such mechanism, previous 
studies [157, 158] have shown the possibility to use alginates applied to PNR. Namely, a 
decomposable freeze-dried alginate gel covered by PGA mesh was employed in a 50 mm 
gap in a cat sciatic nerve model with positive results [157]. The same authors later 
examined the interaction between regenerating axons, Schwann cells and the implanted 
alginate gel [158], showing that alginate gel provides a good environment for axon 
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outgrowth and Schwann cell migration. In another study [128], macro-porous alginate 
fibres encapsulating primary DRGs were produced by wet spinning an alginate solution 
containing dispersed gelatine particles. Marked neurite outgrowth was evident over 150 
μm, indicating that pores and channels created within the alginate were providing a 
favourable environment for neurite development. Other studies have focused on using 
alginate as NGCs luminal fillers, with promising results [159-161].  
 
1.4.1.3 Endogenous Biomaterials/ECM proteins  
Still among the natural-origin biomaterials, ECM endogenous proteins such as 
collagen, fibrin, laminin, and hyaluronic acid (HA) have been highly investigated, since 
they naturally exist in the human body. ECM is a highly organized 3D structure that 
occupies the intercellular space, providing a physical support to tissue. It 
fundamentally acts as a natural scaffold by delivering a matrix, where cells can arrange 
within the connective tissue. Besides delivering the physical support, ECM also 
provides the chemical setting for adequate cellular behavior in terms of survival, 
differentiation and overall fate. Furthermore, Schwann cells express specific 
integrins, such as α1β1, α2β1, α6β1, α6β4, α5β1, αVβ3, that connect to ECM and encourage 
myelination through their interaction with the basal lamina [162]. The important 
interaction between ECM molecules and the nervous system can also be inferred from 
the fact that laminin, fibronectin and collagen are effectively used as coatings of tissue 
culture plastics to enhance Schwann cell and DRGs responses, such as adhesion and 
migration [163]. 
A few recent publications related to the use of endogenous biomaterials applied 
to PNR can be found in Table 6 [164-174]. Furthermore, Fig. 6 summarizes the promising 
results making use of endogenous biomaterials applied to PNR.   




Table 5 - Relevant and recent published works focused on the fabrication of NGC with natural biomaterials. 
Conduit 
material 





Simple spider silk fibers, from 
Nephilia edulis species 
In vitro study, co-culture of ADSCs 
and Schwann cells 
Spider silk fibers represent a suitable NGC filler 




SF and PLLA conduit fabricated 
by electrospinning 
10 mm gap, sciatic nerve defect, rat 
The presence of silk augments VEGF secretion, 
therefore increasing neo-angiogenesis and 
stimulating nerve regeneration. 
 
2018, [119] 
SF conduit with aligned SF 
filaments in the interior 
10 mm gap, sciatic nerve defect, rat 
FluoroGold retrograde tracing and histological 
investigation, SF conduits were able to promote 
nerve regeneration with results approaching those 
provoked by the positive control autografts. 
 
2018, [120] 
Adsorption of gold nanoparticles 
onto SF fibres and electrospinning 
10 mm gap, sciatic nerve defect, rat 
Nerve conduction velocity as well as the 
compound muscle action potential was improved 





Human hair keratin hydrogel was 
injected in a FDA-approved 
conduit 
4 mm gap, tibial nerve defect, mice 
Robust nerve regeneration response, in part 
through activation of Schwann cells. Results 
similar to autograft. 
 
2008, [122] 
Neuragen® collagen conduit 
filled with keratin hydrogel 
10 mm gap, median nerve defect, 
Macaca fascicularis  
Confirms earlier findings in studies using rodents; 
Represents off the shelf alternative to autograft. 
 
2014, [123] 
Double wall PCL containing 
GDNF-microspheres with a 
keratin hydrogel 
10 mm gap, sciatic nerve defect, rat 
Significant increased density of both Schwann 
cells and axons, resulting in the better quality of 
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Chitosan 
Chitosan nerve guides from 
Reaxon® with a longitudinal 
chitosan film as a filler 
15 mm gap, sciatic nerve defect, 
diabetic rat 
Supported robust axonal regeneration and 
functional recovery in healthy animals but also 
demonstrated to be beneficial for the regeneration 




Chitosan film enhanced with 
MSCs 
10 mm gap, sciatic nerve defect, rat 
Chitosan film enhanced with MSCs improved 
functional, electrophysiological and 




Chitosan membranes with 
different degrees of acetylation 
Schwann cell and fibroblast in vitro 
assays 
% of acetylation were found to favor Schwann 
cells invasion and proliferation, presenting at the 
same time low fibroblast adhesion. 
 
2017, [127] 
Combination of MSCs with a 
chitosan a film 
10 mm gap, sciatic nerve defect, rat 
MSCs were useful for the injury because of the 
release of several neurotrophic factors as well as 
the synergistic effect of chitosan accelerating 





Macroporous alginate fibers 
produced with a syringe pump 
In vitro assays with DRGs 
Encapsulation of primary DRGs in macro-porous 
alginate fibers resulted in marked neurite 
outgrowth over 150 μm. 
 
2017, [128] 
3D bioprinting of alginate 
scaffolds conjugated with single 
or dual RGD and YIGSR motifs 
In vitro assays with Schwann cells 
and DRGs 
Printability, mechanical stability, and neurite 
outgrowth were assessed with promising results 
to be used as luminal filler. 
2019, [129] 
  






Collagen is, within the ECM, probably the major organizational and structural 
protein of hard and soft tissues. It provides strength, mechanical stability, structural 
integrity and plays a crucial biological role in a variety of tissues and organs including, 
bone, cartilage, tendon, skin, and cornea[175]. To achieve that, collagen is extremely 
dynamic, undergoing constant modifications to deliver proper physiologic functions 
[131].  Although collagen offers structure to our bodies, protecting and supporting the 
soft tissues, collagen is a relatively simple protein, containing a triple-helical structure 
and the presence of 4-hydroxyproline. Up to this date, 28 collagen types have been 
acknowledged. The types I, II, III, and V constitutes the essential part of collagen in 
bone, cartilage, tendon, skin, and muscle. Collagen can be extracted and purified from 
a variety of sources, typically from bovine and porcine sources. However, in recent years 
new sources are being exploited, such as marine-origin residues [176]. The fact that 
collagen is considered low immunogenic and has good permeability, biocompatibility, 
and biodegradability make it a great component for TE scaffolding strategies [177].  
Collagen use in PNR approaches is also extensively accepted, as the protein often 
exhibits cell-binding domains for aiding neuronal and glial cells attachment and 
migration. In fact, three collagen conduits are commercially available on the market: The 
FDA-approved NeuraGen® and NeuroFlex®, which are both made of type I collagen and 
RevolNerve®, which is made of type I and type III collagens from porcine skin. In a 
pioneering strategy, Neuromaix® containing collagen-based micro-structured 3D 
longitudinal guidance channels is capable of providing mechanical support to sprouting 
DRGs axons and can offer a shielding niche for nerve cells [178].  
Fibrin 
In the human body, fibrin is an integral part of the clotting cascade. When the 
coagulation cascade is triggered after an injury, thrombin activates soluble plasma protein 
fibrinogen, resulting in the formation of an insoluble fibrin milieu. Fibrin is a protein 
involved in the formation of the blood clot [179]. It has found application as a sealant 
glue in neurosurgery for decades, without any reported complications [180]. Furthermore, 
fibrin plays a critical part in PNR, where longitudinally oriented fibrin cables are formed 
spontaneously shortly after injury, as a part of the nerve regeneration process, with the 
intent to direct migration and proliferation of Schwann cells. In fact, the use of fibrin to 
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repair ilioinguinal nerve has shown to have some neuroprotective effect in the injured 
nerve, where less fibrosis and collagen deposition were found [181].  
Fibronectin 
Fibronectin, one of the most complex and intrigguing proteins, is an abundant 
soluble constituent of plasma and other body fluids and part of the insoluble ECM. It also 
mediates a wide variety of cellular interactions with the ECM and plays important roles 
in cell adhesion, migration, growth and differentiation [182]. After extensive 
characterization, it was found that fibronectin expresses the RGD motif, related to cell 
adhesion. However, fibronectin has an extensive variety of practical functions other than 
associate with cell surfaces through integrins. It binds to several biologically important 
molecules that include heparin, collagen and fibrin. The potential of including fibronectin 
for PNR was firstly realized when Whitworth et al. [183] reported a new nerve conduit 
material consisting of orientated strands of the cell adhesive fibronectin. In a 10 mm nerve 
defect in rat, the developed NGC produced the highest rate and amount of axonal 
regeneration, comparable to the one obtained for autografts. Furthermore, increased 
expression of fibronectin can be found in damaged peripheral nerve during Wallerian 
degeneration [184].  
Laminin 
Laminin is a glycoprotein naturally occurring in nerves. It is a component of ECM 
that plays a decisive part in cell-recognition, and therefore influences cell migration, 
differentiation and axonal growth [185]. Laminin can also be perceived as a fundamental 
guiding cue, since the growth cone of regenerating axons is attracted to laminin [186]. To 
make PHBV aligned nanofibers more attractive to neuronal components[187] , laminin 
was adsorbed via electrostatic interactions. Containing both topographic and chemical 
cues suited for Schwann cell alignment and elongation, the developed NGC was 
implanted in a critical sized nerve defect in rat, with 12 mm gap and proved to be suitable 
for such an application. 
 
.




Table 6 - Relevant and recent published works focused on the fabrication of NGC with endogenous biomaterials. 




Oriented collagen tubes with 
adsorbed bFGF 
15 mm, sciatic nerve defect, rat 
The presence of bFGF revealed to be beneficial 
in terms of functional recovery. 
 
2017, [164] 
Blend of collagen and chitosan 
as luminal filler in a PCL 
conduit 
15 mm, sciatic nerve defect, rat 
Axonal regeneration and Schwann cell 
migration, inclusively inducing comparable 





Micro-suturing with fibrin glue 
coaptation 
10 mm, sciatic nerve defect, rat 
Reduced the operating time and increase the 




Epineural repair with fibrin-
glue embedded ADSCs 
10 mm, sciatic nerve defect, rat 
Embedding cellular components in the fibrin 
glue enhanced regeneration, as immunolabeled 
cells could be found at the neuronal repair site 
and near intraneuronal vessels indicating an 




3D hierarchically aligned fibrin 
nanofiber hydrogel through 
electrospinning and molecular 
self-assembly and placed it 
inside chitosan conduits 
10 mm, sciatic nerve defect, rat 
In vitro, directional cell adhesion and migration 
of Schwann cells and DRGs was detected. In 
vivo, results showed that the developed NGC 





Chitosan conduit enriched with 
fibronectin 
15 mm, sciatic nerve defect, rat 
Fibronectin-enriched scaffolds increased 




Schwann cells embedded in a 
matrix of alginate/ fibronectin 
10 mm, sciatic nerve defect, rat 
Synergistic effect when both Schwann cells and 
fibronectin were combined with alginate. 
 
2003, [169] 
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Laminin 
Laminin incorporated PLCL 
nanofibers were produced by 
electrospinning 
In vitro studies with neonatal 
Schwann cells 
Schwann cells expressed bi- and tri-polar 
elongations due to the presence of laminin. 
 
2014, [171] 
Direct injection of laminin in a 
peroneal nerve crush 
Nerve crush defect, rat 
Increased axon presence, larger axon diameter, 
accelerated axon growth and maturity and 
advanced motor function recovery. 
 
2019, [172] 
Hyaluronic acid (HA) 
Electrospinning of a blending 
of HA in PCL 
In vitro cells tests with SH-
SY5Y human neuroblastoma 
cell line 
PCL/HA 95:5 exhibit the most balanced 
properties to meet the required specifications 
for neural cells. 
 
2016, [173] 
Single-channel tubular conduits 
based on hyaluronic acid (HA) 
with and without poly-l-lactide 
acid fibers in their lumen were 
fabricated 
In vitro tests with Schwann 
cells 
impeded the leakage of the cells seeded in their 
interior and made them impervious to cell 
invasion from the exterior, while allowing 
transport of nutrients and other molecules 
needed for cell endurance. The NGC interior 










Fig. 6 - Promising results obtained with natural-origin polymers applied to PNR. A) SEM micrographs of 
transverse section of the oriented collagen-chitosan filler /PCL sheath scaffold and magnification of the 
interior of the conduit; B) SEM micrograph of the aligned fibrin hydrogel nanofiber and its magnification. 
Below, a DRGs where the neurites align along the aligned fibers; C) Transversal cryosections of hyaluronic 
acid conduits cultured for 10 days with Schwann cells in their lumen, after staining with Harris’ 
hematoxylin, Alcian blue, and picrosirius red; and D) Longitudinal section of injured nerve treated with 
PBS (at left) or Laminin (at right), stained with antibodies recognizing NF-h (α-RT97, green). The bar 
graph illustrates significantly increased axon diameter (μm) with laminin treatment. A), B), C) and D) were 
reprinted with the permission from [165], [168], [174] and [172] respectively.
Laminin was also added to collagen gels in a gradient of concentrations with 
interesting effects [188]. For collagen gels without laminin, a typical bimodal response 
of neurite outgrowth was observed, with increased growth at lower concentrations of 
collagen gel. However, in the presence of higher laminin concentrations, the growth 
became independent of the gel stiffness. 
Hyaluronic acid (HA) 
HA is a linear, anionic, non-sulphated glycosaminoglycan that composes the ECM 
of all living tissues. Being a very versatile polymer, it finds applications in diverse areas. 
Furthermore, different molecular weights have an impact on the biological performances, 
being a highly tunable and adaptable polysaccharide [189]. 
Its use is widely spread in TE applications due to its biocompatibility, 
biodegradability and chemical modification easiness. HA is also a very versatile 
biomaterial, which can be prepared in the form of hydrogels, sponges, cryogels, and 
injectable hydrogels [190]. Additionally, HA degradation products seem to exert a 
positive effect in diverse TE areas as they encourage wound healing, tissue restoration, 
and vascularization [191]. The injection of HA in a nerve defect has proved to be 
beneficial for nerve regeneration, since HA groups showed an increase in myelinated 
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axon counts, as well as an increase in retrograde flow, necessary for the regenerative 
process [192]. Furthermore, the advantage of including HA also resides in the fact that it 
can reduce scar formation after nerve injury [193].  
1.4.2. The possibility of patient-specific nerve repair and NGCs 
Personalized TE and regenerative strategies propose a possible solution for 
contemporary untreatable injuries or illnesses. The use of TE triad offers the possibility 
of interminable combinations of cells, scaffolds and growth factors, suggesting endless 
possibilities to customize diagnostic tools, biomedical devices, as well as the final 
treatments [194]. Huge efforts are being carried in laboratories throughout the world to 
personalize the clinical care, catalyzing major advances in the techniques that allow the 
treatment of serious injuries and chronic diseases [195]. The customization and 
individualization of medical care carries huge advantages for the patients and the health 
care systems as well. Targeting the treatments to a specific damage of a patient is critical 
due to innate discrepancies in patient anatomies, injury shapes and gravity, as well as 
individual genetic and proteomic features [196]. The benefit is clear for the patient, i.e. a 
tailor-made treatment according to its own organism features. For the hospitals and 
healthcare systems, the fact that a treatment is 100% suited for that specific patient and 
will not fail, will save time and budget.  
Peripheral nerves are tissues with different geometries and shapes, which vary 
anatomically according to the location within the body. But more importantly, the same 
nerve may vary from person to person with age, according to their medical condition or 
type of injury [197]. Furthermore, the process of nerve regeneration and repair itself is a 
complex biological phenomenon, with vast singularities, that requires an equilibrium at a 
molecular, cellular and tissue level [198]. Overall, many advantages are envisioned when 
using 3D printing for nerve repair and regeneration: (i) fabrication of personalized NGC, 
(2) concomitant assembly of luminal fillers inside NGCs, (3) 3D bioprinting of cells 
within a bioink or into the NGCs, and (4) establishment of growth factor gradients or 
pathways [199]. 
Only recently the hypothesis of patient-specific strategies in nerve regeneration 
has risen with the development of the 3D-printing technology [200]. This was further 
permitted by the combination of 3D imaging machineries and 3D printing methods. 





Johnson et al. [200] successfully established the combination of 3D imaging and 3D 
printing for the design and fabrication of anatomically biomimetic truly patient-specific 
nerve regeneration strategy. It allowed the fabrication of NGCs with complex anatomical 
structures and inner biofunctionalization with neurotrophic factors, to create a sensory 
and a motor pathway (Fig. 7A).  
Hu et al. [201] explored the 3D-printing technology to prepare a bio-conduit with 
designer structures for PNR, where the chosen polymer, cryoGelMA gel, was 
cellularized with ADSCs. When implanted in a 10 mm rat sciatic nerve defect, the 
results were very similar to the autograft in terms of functional recovery. Tao et al. 
[202] were able to 3D-print an hydrogel conduit with customized size, shape and 
structure, providing a physical microenvironment for axonal elongation, where the 
nanoparticles sustained release a drug to facilitate the nerve regeneration.  Zohng et al. 
[203]  described the key technology of 3D peripheral nerve fascicle reconstruction. First, 
a 3D virtual model of internal fascicles was obtained and successfully applied for 3D 
reconstruction for the median nerve (Fig. 7B). 
Exceptional technologies are emerging every day, and 3D printing promises to 
revolutionize the patient-specific healthcare, namely in PNR. 
 
 
Fig. 7 – Patient-specific and 3D printing technologies will allow improving the treatment given to 
patients in the future. A) 3D printed complex nerve pathways from 3D scanned bifurcating nerves. 
Reprinted with permission from [200]. B) Imaging of a 3D model of median nerve, for further precise 
reconstruction. Reprinted with permission from [203], Copyright © 2015, Macmillan Publishers Limited. 
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 CONCLUSIONS 
The complex anatomy and physiology of the PNS makes nerve’s injury very 
problematic and extremely difficult to repair. The full recovery is challenging because of 
the loss of native cues, formation of scar tissue, lack of proper vascularization, and 
inflammation. The diverse treatments used for nerve repair such as coaptation suturing, 
grafts, and conduits pose several limitations when trying to recuperate full functionality. 
Therefore, the development of new NGCs requires a clever combination of the following 
strategies: (i) the development of new polymer or combination of polymers for better 
integration with neural native tissue, (ii) additional of topographical structures to intensify 
neurite alignment and growth, and (iii) biological cues such as growth factors or cellular 
components.  
In what regards the biomaterial choice, there are numerous options to capitalize 
on different properties of each material. Although many exist and can be used, natural 
materials are known to be better integrated by host tissue when compared to synthetic 
ones, more promptly instigating the regenerative mechanisms. The biomaterial 
availability and cost are also essential parameters to consider. Therefore, and in the 
author’s opinion, SF is probably one of the most versatile biomaterials. It can be 
processed in a variety of ways and maintain outstanding mechanical 
properties/suturability and is considered non-immunogenic, with cheap and easy access 
as well as natural distribution. This biomaterial can be used to fabricate the conduit itself, 
as well as anisotropic filling scaffolds in the lumen, in order to be able to treat larger nerve 
gaps. In addition, several fabrication methods can be used for this biomaterial, including 
the crosslinking of the tyrosine groups with an enzymatic mediated system or 
functionalization with growth factors and other molecules of interest. In this context, 
conductive materials can also be used to intensify the needed neurological transmission 
and communication.  
A brief mention must also be made to the potential of 3D printing for patient-
specific nerve reconstructions. The rising of this technology allows to closely reproduce 
features of the native peripheral nerve, with the aim of possibly replace autologous nerve 
grafts. Therefore, the current and future bio-imaging modalities allied with detailed 
printing will permit the production of patient-specific nerve conduits, revolutionizing the 
field. As the scientific community makes advances on the fundamental knowledge related 





to the biological mechanisms behind nerve injury and repair, engineers are able to 
integrate that knowledge in more complex designs, to better mimic natural nerve 
regeneration and patient specificity in respect to anatomy and biology requirements.  
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